Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts

Laboratory Investigation

Volumn 95, Issue 8, 2015, Pages 860-871

  Su, Feng ^a,b   Zhao, Lan ^c   Zhang, Shaoheng ^b   Wang, Jiahong ^b   Chen, Nannan ^b   Gong, Qunlin ^b   Tang, Jinhui ^b   Wang, Hao ^b   Yao, Jianhua ^b   Wang, Qin ^b   Zhong, Ming ^a   Yan, Jian ^c  

^a SHANDONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Dahua Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN; CONNEXIN 43; GROWTH FACTOR; MYELOPEROXIDASE; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTERY LIGATION; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DENSITY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MORTALITY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROPHOTOMETER; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PIG;

ANIMALS; CHROMONES; ISCHEMIC PRECONDITIONING; MORPHOLINES; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938099385     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.64     Document Type: Article

References (30)

1. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest 2005;115:2305-2315.
2. Spear JF, Moore EN. Preconditioning attenuates the shortening of recovery during coronary occlusion in isolated rabbit hearts with D-sotalol-induced long QT intervals. J Cardiovasc Pharmacol 2002; 39: 761-776.
3. Zhou XL, Wan L, Xu QR et al. Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning. J Transl Med 2013;11:251.
4. Kaneko H1, Anzai T, Naito K et al. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction. J Card Fail 2009;15:775-781.
5. Wang Y, Huang CX, Zhou YF et al. ADAMTS-1 expression in rat myocardium after ischemic preconditioning: age-associated differences. Chin Med J (Engl) 2011;124:95-99.
6. Cuevas P, Carceller F, Giménez-Gallego G. Fibroblast growth factors in myocardial ischemia/reperfusion injury and ischemic preconditioning. J Cell Mol Med 2001;5:132-142.
7. Anzai T, Naito K, Kohno T et al. Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am J Physiol Heart Circ Physiol 2011;300:H1907-H1913.
8. Cai ZP, Parajuli N, Zheng X et al. Remote ischemic preconditioning confers late late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 2012;107:277.
9. Dunn CA, Su V, Lau AF et al. Activation of Akt, not connexin 43 protein ubiquitination, regulates gap junction stability. J Biol Chem 2012;287: 2600-2607.
10. Zhang S, Zhao L, Shen L et al. Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment. Arterioscler Thromb Vasc Bio 2012;32:910-923.
11. Barra S, Providência R, Paiva L et al. Early repolarization patterns and the role of additional proarrhythmic triggers. Europace 2013;15: 482-485.
12. Ledvenyiova V, Pancza D, Matejikov JJ et al. Impact of age and sex on response to ischemic preconditioning in the rat heart: differential role of the PI3K-AKT pathway. Can J Physiol Pharmacol 2013;91:640-647.
13. Xu WQ, Yu Z, Xie Y et al. Therapeutic effect of intermittent hypobaric hypoxia on myocardial infarction in rats. Basic Res Cardiol 2011;106: 329-342.
14. Elsherif L, Wang X, Grachoff M et al. Cardiac-specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury. PLoS One 2012;7: e30129.
15. Yang X, Cohen MV, Downey JM. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 2010;24: 225-234.
16. Batra N, Riquelme MA, Burra S et al. Direct regulation of osteocytic connexin 43 hemichannels through AKT kinase activated by mechanical stimulation. J Biol Chem 2014;289:10582-10591.
17. Kim E, Fishman GI. Designer gap junctions that prevent cardiac arrhythmias. Trends Cardiovasc Med 2013;23:33-38.
18. Lim SY, Hsiao ST, Lokmic Z et al. Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model. Tissue Eng Part A 2012;8:2210-2219.
19. Nagy JA, Benjamin L, Zeng H et al. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008;11:109-119.
20. Chacko SM, Ahmed S, Selvendiran K et al. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 2010;299: C1562-C1570.
21. Stubbs SL, Hsiao ST, Peshavariya HM et al. Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev 2012;21:1887-1896.
22. Chen J. Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications. World J Virol 2012;1:154-161.
23. Workman P, Clarke PA, Raynaud FI et al. Drugging the PI3 kinome: from chemical tools to drugs in the clinic. Cancer Res 2010;70:2146-2157.
24. Wu X, He L, Cai Y et al. Induction of autophagy contributes to the myocardial protection of valsartan against ischemia-reperfusion injury. Mol Med Rep 2013;8:1824-1830.
25. Ye Z, Wang N, Xia P et al. Delayed administration of parecoxib, a specific COX-2 inhibitor, attenuated postischemic neuronal apoptosis by phosphorylation Akt and GSK-3β. Neurochem Res 2012;37:321-329.
26. Li X, Mikhalkova D, Gao E et al. Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage density. Am J Physiol Heart Circ Physiol 2011;301: H1932-H1940.
27. Jacobshagen C, Kortlepel S, Unsoeld BW et al. Inhibition of PI3K improves contractility in alpha1-adrenergically stimulated myocardium. Front Biosc 2008;13:6841-6849.
28. Yin X, Wang X et al. Hyperbaric oxygen preconditioning attenuates myocardium ischemia-reperfusion injury through upregulation of heme oxygenase 1 expression: PI3K/Akt/Nrf2 pathway involved. J Cardiovasc Pharmacol Ther 2015 [e-pub ahead of print].
29. Duan Q, Madan ND, Wu J et al. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning. J Mol Cell Cardiol 2015;80:114-125.
30. Yang C, Talukder MA, Varadharaj S et al. Early ischaemic preconditioning requires Akt-and PKA-mediated activation of eNOS via serine1176 phosphorylation. Cardiovasc Res 2013;97:33-43.